Life sciences, covered in full.

A mid-cap-focused investor needed to stress-test the clinical adoption thesis behind a diagnostics company's flagship assay ahead of an earnings call. We sourced and compliance-screened three practicing pathologists and a former payer medical director within four business days, and the investor walked into the call with a grounded view on adoption timelines instead of management's framing alone.

A commercial team wanted to pressure-test new launch messaging before it went in front of the sales force. We fielded a compliance-screened panel of practicing specialists across three regions within a week, and the read came back clear: two of the three proposed claims weren't landing. Better to learn that from a dozen physicians than from six weeks of field data.

A strategy consulting firm needed pharma KOLs for a competitive-intelligence report due to its own client in nine days, too tight a window to build a network from scratch. We sourced and screened five oncology KOLs under the firm's own branding, delivered as interview-ready inputs rather than raw contact names, and the firm shipped on time without ever having to explain who GPR was.